238 related articles for article (PubMed ID: 30668166)
1. β
Li Y; Yuan H; Sun L; Zhou Q; Yang F; Yang Z; Liu D
Genet Test Mol Biomarkers; 2019 Feb; 23(2):124-137. PubMed ID: 30668166
[TBL] [Abstract][Full Text] [Related]
2. Association of β-adrenergic receptor genes polymorphisms with incidence of subsequent cardiovascular events in Han Chinese patients with coronary artery disease.
Li ZG; Wu H; Zhou YL; Chen ZJ; Meng JX; Yang JQ; Chen JY; Zhong SL
Chin Med J (Engl); 2013; 126(24):4679-84. PubMed ID: 24342311
[TBL] [Abstract][Full Text] [Related]
3. Association of β-Adrenergic Receptor Gene Polymorphisms With Acute Coronary Syndrome and Cardiovascular Risk Factors in an Arab Population.
El-Menyar A; Rizk NM; Asim M; Al-Thani H; Elgendy A; Al-Suwaidi J
Angiology; 2016 Sep; 67(8):762-71. PubMed ID: 26602751
[TBL] [Abstract][Full Text] [Related]
4. Influence of ADRB1, ADRB2, and COMT Genetic Polymorphisms on Postoperative Outcomes of Patients Undergoing Cardiac Valve Surgery.
Dai S; Ma W; Qin G; Wang L; Wang E
Clin Ther; 2021 Feb; 43(2):349-359.e2. PubMed ID: 33451866
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms in ADRB1, ADRB2 and CYP2D6 genes and response to beta-blockers in patients with acute coronary syndrome.
Castaño-Amores C; Antúnez-Rodríguez A; Pozo-Agundo A; García-Rodríguez S; Martínez-González LJ; Dávila-Fajardo CL
Biomed Pharmacother; 2023 Dec; 169():115869. PubMed ID: 37952358
[TBL] [Abstract][Full Text] [Related]
6. Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.
Yilmaz A; Kaya MG; Merdanoglu U; Ergun MA; Cengel A; Menevse S
J Clin Lab Anal; 2009; 23(4):237-43. PubMed ID: 19623647
[TBL] [Abstract][Full Text] [Related]
7. Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.
Zhao S; Zhang W; Nie X
BMC Pulm Med; 2019 Nov; 19(1):202. PubMed ID: 31699066
[TBL] [Abstract][Full Text] [Related]
8. Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.
Lanfear DE; Jones PG; Marsh S; Cresci S; McLeod HL; Spertus JA
JAMA; 2005 Sep; 294(12):1526-33. PubMed ID: 16189366
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in Beta-2 Adrenergic Receptor Gene and Association with Tuberculosis.
Azar AF; Jazani NH; Bazmani A; Vahhabi A; Shahabi S
Lung; 2017 Feb; 195(1):147-153. PubMed ID: 27900465
[TBL] [Abstract][Full Text] [Related]
10. Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Pacanowski MA; Zineh I; Li H; Johnson BD; Cooper-DeHoff RM; Bittner V; McNamara DM; Sharaf BL; Merz CN; Pepine CJ; Johnson JA
J Transl Med; 2008 Mar; 6():11. PubMed ID: 18331634
[TBL] [Abstract][Full Text] [Related]
11. Common beta-adrenergic receptor polymorphisms are not associated with risk of sudden cardiac death in patients with coronary artery disease.
Tseng ZH; Aouizerat BE; Pawlikowska L; Vittinghoff E; Lin F; Whiteman D; Poon A; Herrington D; Howard TD; Varosy PD; Hulley SB; Malloy M; Kane J; Kwok PY; Olgin JE
Heart Rhythm; 2008 Jun; 5(6):814-21. PubMed ID: 18534365
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics and healthcare outcomes in patients with chronic heart failure.
Kim KM; Murray MD; Tu W; Robarge J; Ding Y; Brater DC; Flockhart DA
Eur J Clin Pharmacol; 2012 Nov; 68(11):1483-91. PubMed ID: 22543981
[TBL] [Abstract][Full Text] [Related]
13. Association of Gln27Glu and Arg16Gly polymorphisms in Beta2-adrenergic receptor gene with obesity susceptibility: a meta-analysis.
Zhang H; Wu J; Yu L
PLoS One; 2014; 9(6):e100489. PubMed ID: 24960039
[TBL] [Abstract][Full Text] [Related]
14. Significant role of ADRB3 rs4994 towards the development of coronary artery disease.
Kumar S; Mishra A; Srivastava A; Mittal T; Garg N; Mittal B
Coron Artery Dis; 2014 Jan; 25(1):29-34. PubMed ID: 24201118
[TBL] [Abstract][Full Text] [Related]
15. GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease.
Barbato E; Berger A; Delrue L; Van Durme F; Manoharan G; Boussy T; Heyndrickx GR; De Bruyne B; Ciampi Q; Vanderheyden M; Wijns W; Bartunek J
Atherosclerosis; 2007 Oct; 194(2):e80-6. PubMed ID: 17094995
[TBL] [Abstract][Full Text] [Related]
16. beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.
Pacanowski MA; Gong Y; Cooper-Dehoff RM; Schork NJ; Shriver MD; Langaee TY; Pepine CJ; Johnson JA;
Clin Pharmacol Ther; 2008 Dec; 84(6):715-21. PubMed ID: 18615004
[TBL] [Abstract][Full Text] [Related]
17. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
Zak I; Sarecka-Hujar B; Krauze J
Kardiol Pol; 2008 Apr; 66(4):380-6; discussion 387. PubMed ID: 18473266
[TBL] [Abstract][Full Text] [Related]
18. Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.
Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Afzal S; Nyegaard M; Børglum AD; Stender S; Torp-Pedersen C; Køber L; Poulsen HE
Pharmacogenet Genomics; 2012 Oct; 22(10):709-15. PubMed ID: 22760495
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of beta-adrenergic receptors and susceptibility to open-angle glaucoma.
Inagaki Y; Mashima Y; Fuse N; Funayama T; Ohtake Y; Yasuda N; Murakami A; Hotta Y; Fukuchi T; Tsubota K
Mol Vis; 2006 Jun; 12():673-80. PubMed ID: 16785856
[TBL] [Abstract][Full Text] [Related]
20. ADRB1 and ADBR2 gene polymorphisms and the ocular hypotensive response to topical betaxolol in healthy Mexican subjects.
Messina Baas O; Pacheco Cuellar G; Toral-López J; Lara Huerta SF; Gonzalez-Huerta LM; Urueta-Cuellar H; Rivera-Vega MR; Babayan-Mena I; Cuevas-Covarrubias SA
Curr Eye Res; 2014 Nov; 39(11):1076-80. PubMed ID: 24749907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
